| 3/8/2010 | CV | Enzon gets no tenders of 4% convertibles; $115.6 million converted
|
| 2/5/2010 | CV | Enzon launches cash tender offer for its 4% convertible notes due 2013
|
| 1/29/2010 | CV | Enzon to tender for its 4% convertibles with proceeds from asset sale
|
| 11/10/2009 | CV | Enzon asset sale should trigger put option for 4% convertibles, Bank of America Merrill Lynch says
|
| 11/9/2009 | CV | Market Commentary: Ford convertibles regain some ground; Enzon active; Freeport-McMoRan adds; More supply ahead
|
| 5/7/2009 | CV | Enzon records $4.5 million gain on repurchase of convertible notes during first quarter
|
| 2/19/2009 | CV | Enzon to hold off on further convertibles buybacks until discounts widen
|
| 2/19/2009 | CV | Enzon buys back $76.9 million of convertibles in 2008
|
| 1/22/2009 | CV | Market Commentary: Convertibles mixed as activity picks up; Massey Energy trades; Alliant Techsystems comes off slightly
|
| 1/21/2009 | CV | Enzon holders tender mere fraction of 4% convertibles in Dutch auction tender offer
|
| 1/8/2009 | CV | Market Commentary: Convertibles trade mixed: Qwest gains with shares, but AMD sags; Enzon adds on extended tender
|
| 1/8/2009 | CV | Enzon Pharmaceuticals extends partial Dutch auction tender offer for 4% convertibles
|
| 12/8/2008 | CV | Enzon Pharmaceuticals begins partial Dutch auction tender offer for 4% convertibles
|
| 12/5/2008 | CV | Market Commentary: Nabors little changed on lower oil; GM, Ford mixed; Sinclair Broadcast for sale, but no buyers seen
|
| 12/4/2008 | CV | Market Commentary: Prudential longer paper gains; ImClone weaker; Advanced Micro mostly quiet on lowered outlook
|
| 12/3/2008 | CV | Enzon Pharmaceuticals board OKs modified Dutch auction tender for 4% convertibles
|
| 11/6/2008 | CV | Market Commentary: Convertibles softer; General Growth wallows in the teens, Enzon lower; Carrizo down outright
|
| 8/25/2008 | CV | Enzon Pharmaceuticals gets consents needed to amend 4% convertibles
|
| 8/13/2008 | CV | Enzon Pharmaceuticals seeks consents for its 4% convertibles due 2013
|
| 5/7/2008 | CV | Enzon repurchases $59.9 million of its 2008 convertibles
|
| 5/7/2008 | CV | Market Commentary: Legg Mason, Synnex up on debut; Enzon slips on spin-off; Fannie Mae quiet; Transocean, Cheniere gain
|
| 8/20/2007 | CV | Enzon to retire 4.5% convertibles
|
| 7/6/2006 | BTCV | Enzon Pharmaceuticals gets tenders for $137.581 million 4.5% convertibles due 2009
|
| 6/6/2006 | BTCV | Enzon Pharmaceuticals tenders for 4.5% convertibles due 2009
|
| 6/1/2006 | BTCV | Enzon greenshoe exercised, lifting 4% convertibles issue to $275 million
|
| 5/18/2006 | BTCV | New Issue: Enzon prices upsized $225 million seven-year convertibles at cheap end of talk, at 4%, up 25%
|
| 5/18/2006 | CV | Market Commentary: Enzon climbs, Nabors flat on debuts; American Axle gains on conversion expectations; DOV slides further
|
| 5/17/2006 | CV | Market Commentary: American Axle continues rally on conversion option; Greenbrier up on debut; Enzon deal seen as decent
|
| 5/16/2006 | CV | Market Commentary: American Axle surges on possible loophole; DOV Pharmaceuticals falls, Sepracor gains on drug's rejection
|
| 5/16/2006 | BTCV | Enzon $175 million seven-year convertibles talked at 3.5%-4%, up 25%-30%
|
| 5/16/2006 | BTCV | Enzon Pharmaceuticals plans to buy back 4.5% convertibles
|
| 6/24/2005 | CV | Market Commentary: Convertibles mostly extend losses a second day; biotechs waver, but some energy issues see more gains
|
| 2/24/2005 | CV | Market Commentary: Genesis finds bid; UniSource goes past 102; Calpine bonds fall, then bounce back while preferreds gain
|
| 9/17/2004 | CV | Market Commentary: Sepracor issue straddles par; Vitesse goes to 103; EDS firm despite warning; biotechs rally
|
| 2/20/2003 | CV | Market Commentary: Williams boosts entire slate of power names; FCC ruling sends telecoms tumbling
|
| 1/30/2003 | CV | Deutsche sees 9 biotech issues highly probable for distressed exchange
|
| 7/10/2002 | CV | Market Commentary: Stock plunge, earnings worries sideline players, pressure prices
|
| 5/17/2002 | CV | Market Commentary: LifePoint gains in hungry market; El Paso drops on "bad" news
|
| 5/15/2002 | CV | Market Commentary: Pep Boys advances pricing; market run ends in thud
|
